Susceptibility of ceftobiprole against Gram-positive and Gram-negative clinical isolates from 2019 from different European territories

Susceptibility of ceftobiprole against Gram-positive and Gram-negative clinical isolates from 2019 from different European territories

ABSTRACT: Objectives: Ceftobiprole is approved for use in treatment of hospital-associated and community-acquired pneumonia in 16 different European countries and is currently undergoing clinical trials in the United States. Methods: Isolates were collected from hospital laboratories from 16 Europe...

Full description

Bibliographic Details
Main Authors: Stephen Hawser, Nimmi Kothari, Noëlle Jemmely, Nowel Redder
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Ceftobiprole
Europe
Susceptibility
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716522001059

Similar Items

Similar Items